Recombinant Interleukin-1 receptor antagonist for the treatment of ST-segment elevation acute myocardial infarction prevents future heart failure events: a pooled analysis of the VCUART program

Abstract Background ST segment elevation myocardial infarction (STEMI) is associated with an intense acute inflammatory response and an increased risk of death and heart failure (HF). We analyzed the effect of recombinant interleukin-1 receptor antagonist (anakinra) 100 mg subcutaneous injection giv...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2020-11, Vol.41 (Supplement_2)
Hauptverfasser:	Van Tassell, B, Wohlford, G.F, Ho, A.C, Vecchie, A, Garmendia, C, Trankle, C.R, Buckley, L.F, Kadariya, D, Canada, J.M, Carbone, S, Markley, R, Turlington, J.S, Appleton, D, Lipinski, M.J, Abbate, A
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!